Jorge Maspero, Yochai Adir, Mona Al-Ahmad, Carlos A Celis-Preciado, Federico D Colodenco, Pedro Giavina-Bianchi, Hani Lababidi, Olivier Ledanois, Bassam Mahoub, Diahn-Warng Perng, Juan C Vazquez, Arzu Yorgancioglu
Chronic inflammatory airway diseases, including asthma, chronic rhinosinusitis, eosinophilic COPD and allergic rhinitis are a global health concern. Despite the coexistence of these diseases and their common pathophysiology, they are often managed independently, resulting in poor asthma control, continued symptoms and poor quality of life. Understanding disease pathophysiology is important for best treatment practice, reduced disease burden and improved patient outcomes. The pathophysiology of type 2 inflammation is driven by both the innate immune system triggered by pollutants, viral or fungal infections involving type 2 innate lymphoid cells (ILC2) and the adaptive immune system, triggered by contact with an allergen involving type 2 T-helper (Th2) cells...
July 2022: ERJ Open Research